Financials Stericycle, Inc.

Equities

SRCL

US8589121081

Environmental Services & Equipment

Market Closed - Nasdaq 04:00:00 2024-05-01 pm EDT 5-day change 1st Jan Change
44.3 USD -0.96% Intraday chart for Stericycle, Inc. -11.17% -10.61%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 5,815 6,347 5,479 4,599 4,585 4,110 - -
Enterprise Value (EV) 1 8,444 8,074 7,034 6,052 5,849 5,168 5,173 5,182
P/E ratio -16.7 x -110 x -199 x 81.8 x -215 x 37.5 x 22.8 x 13 x
Yield - - - - - - - -
Capitalization / Revenue 1.76 x 2.37 x 2.07 x 1.7 x 1.72 x 1.52 x 1.47 x 1.39 x
EV / Revenue 2.55 x 3.02 x 2.66 x 2.24 x 2.2 x 1.91 x 1.85 x 1.75 x
EV / EBITDA 14.6 x 16.3 x 15.4 x 14 x 13.9 x 10.8 x 9.55 x 8.19 x
EV / FCF 157 x 19.7 x 37.8 x 89 x 52.2 x 23.9 x 20 x 15.7 x
FCF Yield 0.64% 5.09% 2.65% 1.12% 1.92% 4.19% 4.99% 6.39%
Price to Book 2.5 x 2.61 x 2.29 x - - - - -
Nbr of stocks (in thousands) 91,128 91,552 91,863 92,184 92,523 92,785 - -
Reference price 2 63.81 69.33 59.64 49.89 49.56 44.30 44.30 44.30
Announcement Date 2/27/20 2/25/21 2/24/22 2/23/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,309 2,676 2,647 2,705 2,659 2,700 2,799 2,954
EBITDA 1 577.8 495.2 457.8 432.2 420 476.5 541.5 632.5
EBIT 1 452 388.6 352.4 323.7 315.5 374.8 437.9 -
Operating Margin 13.66% 14.52% 13.31% 11.97% 11.86% 13.88% 15.64% -
Earnings before Tax (EBT) 1 -362.8 -56 0.7 78.9 3.3 158.1 256.6 419
Net income 1 -346.8 -57.3 -27.8 56 -21.4 110 180.4 306
Net margin -10.48% -2.14% -1.05% 2.07% -0.8% 4.07% 6.44% 10.36%
EPS 2 -3.810 -0.6300 -0.3000 0.6100 -0.2300 1.182 1.942 3.410
Free Cash Flow 1 53.8 410.7 186.2 68 112 216.5 258 331
FCF margin 1.63% 15.35% 7.03% 2.51% 4.21% 8.02% 9.22% 11.2%
FCF Conversion (EBITDA) 9.31% 82.94% 40.67% 15.73% 26.67% 45.44% 47.65% 52.33%
FCF Conversion (Net income) - - - 121.43% - 196.91% 143.06% 108.17%
Dividend per Share - - - - - - - -
Announcement Date 2/27/20 2/25/21 2/24/22 2/23/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 657.3 664.2 679.8 690.3 670.4 684.3 669.5 653.5 652 664.9 671.2 678.4 682.2
EBITDA 1 92.3 86.3 109 119.3 117.6 111.3 102 96.4 110.3 116.2 118 119.4 123.5
EBIT 1 64.2 59 82 92 90.6 84.7 76 70.3 84.5 90.5 92.63 94.73 96.94
Operating Margin 9.77% 8.88% 12.06% 13.33% 13.51% 12.38% 11.35% 10.76% 12.96% 13.61% 13.8% 13.96% 14.21%
Earnings before Tax (EBT) 1 -8.8 -11.2 18.9 33.1 38.1 19.8 -43.7 6.9 20.3 20.5 41.15 45.2 48.35
Net income 1 -17.2 -14.2 10.5 28 31.8 11.2 -49.5 2 14.9 13.1 28.9 31.47 33.17
Net margin -2.62% -2.14% 1.54% 4.06% 4.74% 1.64% -7.39% 0.31% 2.29% 1.97% 4.31% 4.64% 4.86%
EPS 2 -0.1900 -0.1500 0.1100 0.3000 0.3500 0.1200 -0.5400 0.0200 0.1600 0.1400 0.3100 0.3367 0.3567
Dividend per Share - - - - - - - - - - - - -
Announcement Date 2/24/22 4/28/22 8/5/22 11/3/22 2/23/23 4/27/23 7/27/23 11/2/23 2/28/24 4/25/24 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,630 1,727 1,556 1,453 1,263 1,058 1,063 1,072
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 4.551 x 3.487 x 3.398 x 3.362 x 3.007 x 2.219 x 1.962 x 1.695 x
Free Cash Flow 1 53.8 411 186 68 112 217 258 331
ROE (net income / shareholders' equity) 9.8% 8.65% 8.35% 7.82% -0.87% 6.4% 7.2% 10.8%
ROA (Net income/ Total Assets) -5.38% -0.95% -0.5% 1.04% -0.4% 2.3% 3.6% 5.6%
Assets 1 6,446 6,013 5,527 5,404 5,343 4,780 5,010 5,464
Book Value Per Share 25.60 26.50 26.10 - - - - -
Cash Flow per Share 2 3.280 5.790 2.880 3.600 - 3.430 3.860 5.600
Capex 1 194 120 117 132 131 150 149 147
Capex / Sales 5.87% 4.47% 4.42% 4.89% 4.94% 5.55% 5.32% 4.98%
Announcement Date 2/27/20 2/25/21 2/24/22 2/23/23 2/28/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
44.3 USD
Average target price
61.8 USD
Spread / Average Target
+39.50%
Consensus
  1. Stock Market
  2. Equities
  3. SRCL Stock
  4. Financials Stericycle, Inc.